Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro

Jens M Baron1, Ruth Heise, William S Blaner

  • 1Department of Dermatology and Allergology, University Hospital of the RWTH, Aachen, Germany. JensMalte.Baron@post.rwth-aachen.de

Insights

Retinoic acid (RA) metabolites, previously thought inert, show significant gene regulatory activity in skin cells. This finding impacts understanding of dermatological drug effects and skin homeostasis.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Biochemistry

Background:

  • Retinoic acid (RA) regulates critical cellular processes in skin, including growth, differentiation, and inflammation.
  • The metabolic fate and functional impact of retinoid transformation products in skin remain incompletely understood.

Purpose of the Study:

  • To investigate the transcriptional activity of all-trans-, 9-cis-, and 13-cis-retinoic acid and their 4-oxo-metabolites in normal human epidermal keratinocytes (NHEKs) and dermal fibroblasts.
  • To identify novel genes and proteins modulated by retinoids in skin cells.

Main Methods:

  • Gene and protein expression profiling techniques were employed.
  • Methods included cDNA microarrays, two-dimensional gel electrophoresis, and MALDI-MS.
  • Functional activity was assessed in NHEKs and dermal fibroblasts.

Main Results:

  • Contrary to previous assumptions, 4-oxo-retinoic acid metabolites demonstrated potent, isomer-specific transcriptional regulatory activity.
  • Novel genes influenced by RA treatment were identified, including those involved in retinoid and corticosteroid biotransformation, antioxidant defense, and structural/transport proteins.
  • These findings highlight the complex regulatory roles of RA and its metabolites in skin homeostasis.

Conclusions:

  • Retinoic acid 4-oxo-metabolites are not inert but possess significant biological activity in skin cells.
  • This research expands the understanding of retinoid action in the skin and their modulation of physiological and pharmacological effects.
  • The identified genes provide new insights into the regulatory systems governing skin homeostasis and drug responses.